Merck RSV antibody Enflonsia gets USFDA okay for infants Ruchika Sharma10 Jun 2025 5:36 AMRahway: Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA)...
Merck posts positive phase 3 trials results evaluating Enlicitide Decanoate in adults with Hyperlipidemia Ruchika Sharma10 Jun 2025 3:30 AMRahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the first two of three...
Merck, Daiichi Sankyo withdraw US appication for patritumab deruxtecan for advanced or metastatic EGFR-mutated non-small cell lung cancer Ruchika Sharma31 May 2025 9:48 AMRahway: Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, have announced that the Biologics License Application...
Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma Ruchika Sharma15 May 2025 6:15 AMRahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug Administration...
Integrated digital health gateway ekincare raises investment from MSD IDEA Studio Asia Pacific Ruchika Sharma29 April 2025 8:00 AMTo date, ekincare has raised a total funding of USD22M since 2015.
Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion Ruchika Sharma27 April 2025 10:30 AMBengaluru: Merck KGaA, a science and technology company, is in late-stage negotiations to buy SpringWorks Therapeutics, a US based...
Bayer arm AskBio elects Independent Director Dr Laura Sepp Lorenzino to Board Ruchika Sharma9 April 2025 6:00 AMResearch Triangle Park: AskBio Inc., a gene therapy company wholly owned and independently operated subsidiary of Bayer AG, has announced...
Merck Capvaxive gets European Commission nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Ruchika Sharma27 March 2025 6:45 AMEuropean Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and...
Merck gets rights to develop, commercialize Jiangsu Hengrui Pharma heart drug worldwide, excluding Greater China region Ruchika Sharma25 March 2025 11:52 AMThe transaction is expected to close in the second quarter of 2025.
Merck injected version of Keytruda faces possible patent challenge: Report Ruchika Sharma6 March 2025 11:36 AMMerck's newly developed injected version of its blockbuster cancer drug, Keytruda, may be at the center of a potential patent dispute,...
Merck to increase workforce at Indian sites by year end Ruchika Sharma1 March 2025 10:24 AMDrug Maker Merck expects to boost employment in India with increment in its workforce across its India sites by the end of the year, a senior...
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma Ruchika Sharma27 Feb 2025 9:47 AMRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
